Skip to main content
. 2018 Jul 2;9(7):331. doi: 10.3390/genes9070331

Table 3.

Comparison of ALK–EML4 fusion detection results for clinical samples.

Method Sample TP Rate TP TN FP FN Sensitivity Specificity
BWA-ALN + FACTERA 286 0.35% 1 270 0 15 6.25% 100.00%
BWA-ALN + CREST 286 1.40% 4 270 0 12 25.00% 100.00%
BWA-MEM + FACTERA 286 0.70% 2 270 0 14 12.50% 100.00%
BWA-MEM + CREST 286 2.80% 8 270 0 8 50.00% 100.00%
SEGF 286 3.85% 11 270 0 5 68.75% 100.00%